Delivery Order FA486121D0004-FA486121F0100
Award Date 3/18/21
Potential Completion Date 3/17/22
Potential Value $62K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Nellis AFB, NV, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Air Force Air Combat Command awarded a $124,588.79 firm fixed price delivery order to Genomic Health, Inc. for Oncotype DX cancer testing services during the ordering period from March 2023 through March 2024. Genomic Health is a subsidiary of Exact Sciences Corporation which will perform the testing through its laboratory services division Exact Sciences Laboratories. The delivery order was awarded without a set-aside designation to support the Air Force's cancer screening...
- Genomic Health, Inc., a subsidiary of Exact Sciences Corp, has been awarded a $141,858.59 firm fixed price delivery order contract by the Department of the Air Force Air Combat Command. The contract calls for Genomic Health to provide Oncotype DX cancer testing services to support the agency's medical programs. Performance will take place in Las Vegas, Nevada. No set-aside provisions were applied to this award. Genomic Health will leverage its subsidiary Exact Sciences Laboratories to fulfill...
- This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...
- This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
- This is a $6,907.92 firm fixed-price purchase order awarded by the U.S. Air Education and Training Command to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract is for the provision of Oncotype Pathology Test services, which are advanced genetic testing services used to support cancer screening, treatment selection, and disease monitoring. Genomic Health, Inc. is an experienced federal contractor, having previously secured multiple Indefinite Delivery Vehicles...
- This federal contract award is for the Oncotype DX laboratory test, which was awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, awarded by the Department of the Army Medical Command, has a potential value of $250,000.00 and is a firm fixed price purchase order with no set-aside designation. Genomic Health has a history of federal contracts to provide cancer testing services, including its Oncotype DX portfolio, to the Defense Health Agency, Department...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
- This federal contract award is for the provision of 2 Oncotype DX Pathology Tests by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract was awarded by the Air Education and Training Command, a defense agency, and has a ceiling value of $6,907.92. It is a firm fixed-price delivery order contract under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does not have a set-aside designation. Genomic Health, Inc. is the...
- The Defense Health Agency awarded Genomic Health, Inc. a $145,066.32 firm fixed-price BPA call for Oncotype IQ genomic testing services, with an ultimate completion date of September 7, 2026. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in advanced genetic testing services focused on oncology diagnostics, particularly the Oncotype DX portfolio of gene expression assays. These tests support cancer screening, treatment selection, and disease monitoring across breast,...
- The Defense Health Agency awarded a $69.5K delivery order to Exact Sciences Corporation for Oncotype DX breast cancer genomic testing services, with performance at Eglin Air Force Base in Florida. This firm fixed-price contract, awarded September 26, 2025, represents a task order under the company's existing blanket purchase agreement with DHA for oncology testing services. Oncotype DX analyzes gene expression within breast cancer tumor tissue samples obtained from core biopsies or surgical...